FALCO HOLDINGS Co., Ltd.
4671.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$26.73B
Close$
$3427.38
28.4% upside
Current Fair Value
28.4% upsideUndervalued by 28.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $26.73 Billion |
|---|---|
| Enterprise Value | $19.07 Billion |
| Dividend Yield | $126.50 (4.74%) |
| Earnings per Share | $201.04 |
| Beta | 0.28 |
| Outstanding Shares | 10,001,874 |
Return
| Return on Equity | 8.19% |
|---|---|
| Return on Assets | 5.60% |
| Return on Invested Capital | 9.50% |
Valuation & Multiples
| P/E Ratio | 12.83 |
|---|---|
| PEG | 64.37 |
| Price to Sales | 0.61 |
| Price to Book Ratio | 1.05 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | 7 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About FALCO HOLDINGS Co., Ltd.
1,037 employees
CEO: Tadashi Yasuda FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institution...